Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors.
AUTHORS
Bertron
JL ,
Durvernay
MT ,
Mitchell
SG ,
Smith
ST ,
Maeng
JG ,
Blodaum
AL ,
Davis
DC ,
Meiler
J ,
Hamm
HE ,
Lindsley
CW .
ACS Chemical Neuroscience. ; 12(24).
4524-4534
- PMID: 34855359 [PubMed].